A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects
Clinical trial NCT06858657 · COMPLETED
Trial details
- NCT number
- NCT06858657
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-17
- Primary completion
- 2024-11-18
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.